Get the full picture
Sign in to uncover key details.
Shaperon
Business Services · South Korea · 11-50 Employees
View Company Info for Free
Overview
Headquarters
174-10 Jagok-ro Gangnam-gu Ste 218 / 608...Website
www.shaperon.comRevenue
<$5 MillionIndustry
About Shaperon
Shaperon is a clinical-stage biotech company developing novel inflammasome inhibitors in the Republic of Korea. Its unique mechanism of action via GPCR19-P2X7 modulation suppresses a broad spectrum of inflammatory cytokines by controlling both priming and activation phase of inflammasome. Shaperon is engaged in multiple clinical programs in atopic dermatitis, COVID-19, Alzheimer's disease, idiopathic pulmonary fibrosis (IPF), ulcerative colitis, and NASH. Additionally, Shaperon is developing multi-valent and multi-specific nanobodies in oncology and viral infections.Explore more
Shaperon Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Shaperon Tech Stack
A closer look at the technologies used by Shaperon
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Shaperon
Sign Up For FreeTo access detailed company insights
Shaperon is a clinical-stage biotech company developing novel inflammasome inhibitors in the Republic of Korea. Its unique mechanism of action via GPCR19-P2X7 modulation suppresses a broad spectrum of inflammatory cytokines by controlling both priming and activation phase of inflammasome. Shaperon is engaged in multiple clinical programs in atopic... Read More
